BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fattahi S, Ahmed SK, Park SS, Petersen IA, Shumway DA, Stish BJ, Yan ES, Remmes NB, Mutter RW, Corbin KS. Reirradiation for Locoregional Recurrent Breast Cancer. Adv Radiat Oncol 2021;6:100640. [PMID: 33506143 DOI: 10.1016/j.adro.2020.100640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Mutter RW, Choi JI, Jimenez RB, Kirova YM, Fagundes M, Haffty BG, Amos RA, Bradley JA, Chen PY, Ding X, Carr AM, Taylor LM, Pankuch M, Vega RBM, Ho AY, Nyström PW, McGee LA, Urbanic JJ, Cahlon O, Maduro JH, MacDonald SM. Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee. Int J Radiat Oncol Biol Phys 2021;111:337-59. [PMID: 34048815 DOI: 10.1016/j.ijrobp.2021.05.110] [Reference Citation Analysis]
2 Gabrys D, Kulik R, Namysł-Kaletka A. Re-irradiation for intra-thoracic tumours and extra-thoracic breast cancer: dose accumulation, evaluation of efficacy and toxicity based on a literature review. Br J Radiol 2021;:20201292. [PMID: 34826226 DOI: 10.1259/bjr.20201292] [Reference Citation Analysis]
3 Choi JI, Khan AJ, Powell SN, McCormick B, Lozano AJ, Del Rosario G, Mamary J, Liu H, Fox P, Gillespie E, Braunstein LZ, Mah D, Cahlon O. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation. Radiother Oncol 2021;165:142-51. [PMID: 34688807 DOI: 10.1016/j.radonc.2021.10.010] [Reference Citation Analysis]
4 Luo W, Ali YF, Liu C, Wang Y, Liu C, Jin X, Zhou G, Liu NA. Particle Therapy for Breast Cancer: Benefits and Challenges. Front Oncol 2021;11:662826. [PMID: 34026640 DOI: 10.3389/fonc.2021.662826] [Reference Citation Analysis]